HMT advised Premier Research Group plc (“PRG”) an international pharmaceutical services group on the acquisition of Pharmdata Inc (“PharmData”) and Imform GmbH (“Imform”) for up to £12.0 million and £4.5 million respectively.
PharmData is a Contract Research Organisation (“CRO”) that specialises in clinical data management, statistical analysis, medical writing, electronic archiving and project management services for the pharmaceutical, biotechnology, and medical device industries. The business, which was set up in 1994, is based in Atlanta, USA and employs 40 people.
Imform is a full service CRO specialising in providing outsourced clinical services. The company has the experience and technology necessary to develop drugs from Phase I to Phase IV for the pharmaceutical and biotechnology industries. The business, which was set up in 1991 is headquartered in Darmstadt near Frankfurt and has operations across Central and Eastern Europe.
Dr Simon Yaxley Chief Executive of Premier Research commented:
“We are delighted with these acquisitions which represents an important step in our strategy of building a leading international contract research organisation. We can now provide a wider and more comprehensive geographical coverage which will further enhance our service offering amongst our ever growing customer base.”
“We are delighted to be involved with PRG in developing its buy and build strategy. We believe that these acquisitions provide PRG an exciting opportunity to continue its success.”